Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions

Treatments

  • International Guideline concordance of empiric antibiotic use in community-acquired pneumonia
    Sergi Pascual Guardia, Judith Marin-Corral, Manuela Carugati, Stefano Aliberti, Oriol Sibila, Francisco Sanz, Giovanni Sotgiu, Pedro J. Marcos, Martin Kolditz, Marcos I. Restrepo
    European Respiratory Journal Sep 2020, 56 (suppl 64) 4669; DOI: 10.1183/13993003.congress-2020.4669
  • PGE2 and PGI2 restore defective lung epithelial progenitors induced by cigarette smoke
    Xinhui Wu, Sophie Bos, Lars Verkleij, Angela D’Ambrosi, Martina Schmidt, Loes Kiestemaker, Reinoud Gosens
    European Respiratory Journal Sep 2020, 56 (suppl 64) 4785; DOI: 10.1183/13993003.congress-2020.4785
  • Changes in DNA methylation after corticosteroids treatment in COPD patients
    Jos van Nijnatten, Corry-Anke Brandsma, Pieter Hiemstra, Wim Timens, Maarten Van Den Berge, Alen Faiz
    European Respiratory Journal Sep 2020, 56 (suppl 64) 4783; DOI: 10.1183/13993003.congress-2020.4783
  • Multidisciplinary team meetings dedicated to children interstitial lung diseases (chILD) – a 2-years experience
    Nadia Nathan, Alice Hadchouel, Maryem Sari Hassoun, Céline Lustremant, Delphine Habouria, Annick Clement, Ralph Epaud, . For The Respirare And Respifil Groups
    European Respiratory Journal Sep 2020, 56 (suppl 64) 5292; DOI: 10.1183/13993003.congress-2020.5292
  • Non-contrast-enhanced assessment of lung perfusion in CF patients during respiratory tract exacerbation using Fourier decomposition magnetic resonance imaging (FDMRI)
    Andrea Mazzaro, Mirco Ros, Silvia Bertolo, Pierluigi Ciet, Francesco Serafini, Giovanni Morana
    European Respiratory Journal Sep 2020, 56 (suppl 64) 4338; DOI: 10.1183/13993003.congress-2020.4338
  • Effects of nintedanib on progression of ILD in patients with fibrosing ILDs and a progressive phenotype: further analyses of the INBUILD trial
    Kevin R. Flaherty, Athol U. Wells, Vincent Cottin, Anand Devaraj, Yoshikazu Inoue, Luca Richeldi, Simon L. F. Walsh, Martin Kolb, Dirk Koschel, Teng Moua, Susanne Stowasser, Rainer-Georg Goeldner, Rozsa Schlenker-Herceg, Kevin K. Brown
    European Respiratory Journal Sep 2020, 56 (suppl 64) 4578; DOI: 10.1183/13993003.congress-2020.4578
  • Changes in biomarkers with nintedanib plus sildenafil in subjects with IPF by presence of emphysema in the INSTAGE trial
    Eric White, Vincent Cottin, Martin Kolb, Toby M Maher, Carina Ittrich, Claudia Diefenbach, Klaus B Rohr, Manuel Quaresma, Bruno Crestani
    European Respiratory Journal Sep 2020, 56 (suppl 64) 5189; DOI: 10.1183/13993003.congress-2020.5189
  • FACE: Phenotyping analysis of chronic heart failure (CHF) patients with sleep disordered breathing (SDB) indicated for adaptive servoventilation (ASV): 2-year follow-up results
    Renaud Tamisier, Thibaud Damy, Jean-Marc Davy, Johan Verbraecken, Sebastien Bailly, Florent Lavergne, Alain Palot, Frederic Goutorbe, Jean-Louis Pepin, Marie-Pia D'Ortho
    European Respiratory Journal Sep 2020, 56 (suppl 64) 4737; DOI: 10.1183/13993003.congress-2020.4737
  • Effects of nintedanib on markers of epithelial damage in subjects with IPF: data from the INMARK trial
    Gisli Jenkins, Imre Noth, Moisés Selman, Vincent Cottin, Yasuhiko Nishioka, Jin Woo Song, Antje Prasse, Eric S White, Carina Ittrich, Claudia Diefenbach, Klaus B Rohr, Susanne Stowasser, Toby M Maher
    European Respiratory Journal Sep 2020, 56 (suppl 64) 5187; DOI: 10.1183/13993003.congress-2020.5187
  • Effects of nintedanib in patients with progressive fibrosing ILDs and differing baseline FVC: further analyses of the INBUILD trial
    Claudia Valenzuela, Toby M Maher, Francesco Bonella, Alberto Pesci, Stephane Jouneau, Nina M Patel, Evans R Fernández Pérez, Rainer-Georg Goeldner, Susanne Stowasser, Rozsa Schlenker-Herceg, Manuel Quaresma, Vincent Cottin
    European Respiratory Journal Sep 2020, 56 (suppl 64) 4577; DOI: 10.1183/13993003.congress-2020.4577

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 240
  • Acute lung injury and critical care (71)
  • Asthma and allergy (594)
  • CF and non-CF bronchiectasis (248)
  • COPD and smoking (875)
  • Epidemiology, occupational and environmental lung disease (212)
  • Genetics (50)
  • Interstitial and orphan lung disease (453)
  • Lung biology and experimental studies (265)
  • Lung cancer (269)
  • Lung imaging (26)
  • Lung structure and function (294)
  • Mechanisms of lung disease (144)
  • Paediatric pulmonology (371)
  • Pulmonary pharmacology and therapeutics (140)
  • Pulmonary vascular disease (484)
  • Respiratory clinical practice (154)
  • Respiratory infections and tuberculosis (884)
  • Sleep medicine (256)

Custom Text goes here

  • Most Read
  • Twitter
Loading
  • Pathogenesis of COVID-19 from a cell biology perspective
  • Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis
  • The effects of coronavirus on human nasal ciliated respiratory epithelium
  • Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective
  • Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study
More...

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • CME
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Submit a manuscript
  • ERS author centre

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2021 by the European Respiratory Society